1. Home
  2. CABA vs FLXS Comparison

CABA vs FLXS Comparison

Compare CABA & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

N/A

Current Price

$1.48

Market Cap

339.1M

Sector

Health Care

ML Signal

N/A

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

N/A

Current Price

$74.70

Market Cap

327.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
CABA
FLXS
Founded
2017
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
339.1M
327.6M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
CABA
FLXS
Price
$1.48
$74.70
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$11.75
★ $87.00
AVG Volume (30 Days)
★ 4.9M
55.5K
Earning Date
11-05-2026
10-26-2026
Dividend Yield
N/A
★ 1.38%
EPS Growth
10.26
★ 70.99
EPS
N/A
★ 1.24
Revenue
N/A
★ $459,178,000.00
Revenue This Year
N/A
$3.48
Revenue Next Year
N/A
$5.29
P/E Ratio
★ N/A
$58.87
Revenue Growth
N/A
★ 4.10
52 Week Low
$1.18
$34.59
52 Week High
$4.23
$90.65

Technical Indicators

Market Signals
Indicator
CABA
FLXS
Relative Strength Index (RSI) 41.97 44.26
Support Level N/A $68.68
Resistance Level $1.63 $78.44
Average True Range (ATR) 0.14 3.82
MACD 0.04 -0.19
Stochastic Oscillator 63.33 50.84

Price Performance

Historical Comparison
CABA
FLXS

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

Share on Social Networks: